Zoledronic acid linked to early increase in sclerostin levels
(HealthDay)—Women with postmenopausal osteoporosis treated with zoledronic acid show an early increase in serum levels of the negative regulator of bone formation, sclerostin, that return close to baseline after 360 days, ...
Apr 29, 2013
0
0